Industry Minister Tim Ayres has imposed levies of up to 113 per cent on some products, despite warnings these could harm the ...

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in ...

Shadow home secretary Chris Philp accuses the government of trading "national security for economic crumbs off the Chinese ...

This investment coincides with China’s burgeoning presence in the pharmaceutical industry, driven by an uptick in innovative ...

Americans spent more than $700 billion on prescription medicines last year. However, many of them remain worried about the safety of their medications.

AstraZeneca’s investment will “span the value chain” of drug research and development and comes amid a prolonged surge in ...

Europe hedges its bets as Starmer courts China, war tech backfires in Ukraine, AstraZeneca doubles down, and Denmark asserts ...

This significant commitment to China, the company's second-biggest market, comes despite recent scandals, including the ...

British drugmaker's largest investment in China announced during UK Premier Keir Starmer's visit to Beijing - Anadolu Ajansı ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.

BEIJING, Jan. 30 (Xinhua) -- China has become a critical contributor to scientific innovation and advanced manufacturing, as well as a driving force for common prosperity worldwide, Pascal Soriot, CEO ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.